Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetic Retinopathy

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...

Photoreceptors and Visual Pathways

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...

Alzheimer Disease l: Introduction

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pachy-reticular pseudodrusen associated with pachyvitelliform maculopathy.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2026

Same author

Centenarian patients with neovascular age-related macular degeneration.

Retina (Philadelphia, Pa.)·2026

Same author

SD-OCT AND OCTA: Distinct or Additional Information on Neovascular Activity? The COCTAEYL Study.

Retina (Philadelphia, Pa.)·2026

Same author

Intravitreal Tamponade Agents in Vitreoretinal Surgery: Current Advances and Future Directions.

Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde·2026

Same author

Lacquer Cracks Detection and Measurement Using Black-on-White Infrared Reflectance and Late-Phase Indocyanine Green Angiography in Pathologic Myopia.

Ophthalmology science·2025

Same author

Tolerability of 0.5% Liposomal Ozonated Oil Versus 0.6% Povidone-Iodine in Antiseptic Prophylaxis for Intravitreal Injections.

Ophthalmology and therapy·2025

Search research articles

Related Experiment Video

Updated: Jun 1, 2026

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

Age-related macular degeneration.

Giuseppe Querques¹, Fernando Onofrio Avellis, Lea Querques

¹Service d'Ophtalmologie, Centre Hospitalier Intercommunal Créteil, Université Paris-Est Créteil, Créteil, France;

Clinical Ophthalmology (Auckland, N.Z.)

|June 10, 2011

Summary

New insights into age-related macular degeneration (AMD) reveal better understanding of its pathogenesis. Current treatments focus on anti-vascular endothelial growth factor drugs for exudative AMD, while atrophic AMD lacks effective therapies.

Keywords:

age-related macular degeneration antivascular endothelial growth factor choroidal neovascularization drusen geographic atrophy

More Related Videos

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

A Workflow to Quantitatively Determine Age-Related Macular Degeneration Lesion-Specific Variations in Fundus Autofluorescence

A Workflow to Quantitatively Determine Age-Related Macular Degeneration Lesion-Specific Variations in Fundus Autofluorescence

Published on: May 26, 2023

Related Experiment Videos

Last Updated: Jun 1, 2026

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

A Workflow to Quantitatively Determine Age-Related Macular Degeneration Lesion-Specific Variations in Fundus Autofluorescence

A Workflow to Quantitatively Determine Age-Related Macular Degeneration Lesion-Specific Variations in Fundus Autofluorescence

Published on: May 26, 2023

Area of Science:

Ophthalmology
Pathogenesis Research
Therapeutic Development

Background:

Age-related macular degeneration (AMD) is a leading cause of vision loss.
Understanding the biochemical and pathological pathways of AMD is crucial for developing effective treatments.

Purpose of the Study:

To review current knowledge on the pathogenesis of age-related macular degeneration (AMD).
To assess the latest treatment strategies for both exudative and atrophic AMD.

Main Methods:

Review of biochemical and pathological pathways in AMD genesis.
Analysis of treatment strategies for exudative AMD, including intravitreal injections.
Evaluation of therapeutic options for atrophic AMD.

Main Results:

Enhanced understanding of the biochemical and pathological mechanisms underlying AMD.
Intravitreal anti-vascular endothelial growth factor (VEGF) drugs are the primary treatment for exudative AMD, though administration strategies are not yet standardized.
Currently, no definitive therapies exist for atrophic AMD, despite ongoing experimental pharmacological research.

Conclusions:

Significant progress has been made in understanding AMD pathogenesis.
While exudative AMD has new treatment options, atrophic AMD remains a challenge requiring further research and development of novel therapies.